AGC acquires in two fields
Japan’s AGC has completed the acquisition of Malgrat Pharma Chemicals (MPC), a maker of synthetic APIs based in Spain, from Boheringer Ingelheim.
Charles River Laboratories (CRL) has agreed to acquire CiToxLab in a €448 million merger that will create the largest player in the early stage CRO space for the pharmaceuticals industry. The deal is expected to close in Q2, subject to labour consultations, regulatory requirements and customary closing conditions.
Italian CDMO and generic API maker Olon has acquired its compatriot CapuaBioservices, which provides
WuXi AppTec is to expand its facilities in San Diego, by establishing a centre of excellence in screening, discovery biology, pharmacology and small molecule proc
API and finished dosage form manufacturer Cambrex is investing $1 million at its site in High Point, North Carolina, in response to a growing number of new projects.